Skip to content
S8286Senate2021-2022 SessionSame asA9413

Require Prenatal Test Warnings

Official title

“Requires a written notice on the occurrence of a false-positive result for any condition tested during a prenatal test”

Sponsor James SkoufisSD-39+2 co-sponsorsAffects Health
Status
In Senate Committee
Rules
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Rules

What's happening

This bill requires written notice about false-positive rates for all prenatal tests, ensuring patients are informed before and after testing.

Why it matters

  1. Ensures patients receive detailed, standardized information about the likelihood of false-positive results. for each condition tested in prenatal screening, promoting informed decision-making and reducing possible confusion or undue anxiety caused by misunderstood results.

  2. Requires transparency from test manufacturers, hospitals, and laboratories. by mandating the sharing of the actual data used to calculate false-positive rates, and prohibits offering tests for conditions if this data isn’t available—potentially raising the bar for scientific rigor in prenatal screening.

  3. Mandates that clear, plain-language notices about false-positive rates be given at multiple points. (before testing, with results, and in all related materials), which may help patients ask better questions and have fuller discussions with their healthcare providers.

  4. Protects the autonomy of both patients and healthcare professionals. by allowing practitioners to use their judgment in recommending tests, and letting patients request specific conditions be tested (with disclosure requirements still applying when data is available), thus balancing transparency with medical flexibility.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Pregnant patients and potential parents

    They would receive written information about false-positive results before prenatal testing and with results, with an exception allowing available tests specifically requested by patients before receiving testing materials.

  • Prenatal test manufacturers, suppliers and advertisers

    They would have to provide notices including the percentage of positive results that are false positives before testing, with results and with testing materials.

  • Hospitals and prenatal care providers

    They would have to provide notices unless the test entity already does so and could not offer testing for conditions lacking laboratory false-positive data, subject to the patient-request exception.

  • New York State Department of Health

    It would develop the required plainly worded notices, which must include all laboratory data used to determine false-positive results.

Headline styles

Require Prenatal Test Warnings

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 39

Chair, Investigations And Government Operations

History

  1. Committed to rules
  2. Advanced to third reading
  3. 2nd report cal.
  4. 1st report cal.1342
  5. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9413Assembly

Disclose False Prenatal Positives

In Assembly Committee · Health · Sponsor Judy Griffin

Impact 5 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8286

IN SENATE

February 9, 2022

Introduced by Sens. SKOUFIS, KAPLAN -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to requiring a written notice on the occurrence of a false-positive result for any condition tested during a prenatal test

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 2533 to read as follows:

§ 2533. Disclosure of information concerning prenatal testing. a. The following terms as used in this section shall mean the following:

1. "Laboratory" shall have the same meaning as is set forth in section five hundred seventy-one of this chapter.

2. "Prenatal testing services" means any service provided by a hospital to identify potential problems with a pregnancy or the relative likelihood of abnormalities in a fetus. Such services shall include but not be limited to services that test placental tissue or the blood of a pregnant patient.

3. "Material" means any advertisement, promotional brochure, website or documentation that may be presented to a patient or a potential parent to recommend prenatal testing services offered by a hospital.

4. "Percentage of positives being a false-positive" means the ratio of the number of false-positive results divided by the sum of the number of false-positive results and the number of true positives.

b. Every prenatal test shall include a written notice, provided by the entity which manufactured, supplied, or otherwise created such test or which advertised performing prenatal tests, about the occurrence of a false-positive result, including but not limited to the percentage of positives being a false-positive, for any condition tested during such prenatal test. Such written notice shall be provided to a patient or a potential parent: (i) prior to any prenatal test; (ii) with such test results; and (iii) with any materials provided by the entity providing or facilitating the prenatal testing. Such written notice shall be developed by the department and shall include all data used by a labora-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14192-06-2

tory to determine such false-positive results. If such data cannot be obtained for a condition tested during a prenatal test from the laboratory, such condition shall not be offered to a patient or a potential parent to be included in the prenatal testing services. Such written notice shall be plainly worded and prominently displayed in any material presented to a patient or a potential parent about prenatal testing services.

c. Every hospital or health care provider offering prenatal testing services shall provide a written notice about the occurrence of a falsepositive result, which may include the percentage of positives being a false-positive as required under subdivision b of this section, for any condition tested during such prenatal test; provided, however, such notice shall not be required if such notice is provided to the patient or potential parent by the entity which manufactured, supplied, or otherwise created such test or which advertised performing prenatal tests under subdivision b of this section. Such written notice shall be provided to a patient or a potential parent prior to any prenatal test and when a patient or a potential parent receives such test results. Such written notice shall be developed by the department and shall include all data used by a laboratory to determine such false-positive results. If such data cannot be obtained for a condition tested during a prenatal test from the laboratory, such condition shall not be offered to a patient or a potential parent to be included in the prenatal testing services. Such written notice shall be plainly worded and prominently displayed in any material presented to a patient or a potential parent about prenatal testing services.

d. Notwithstanding the provision of subdivision b or c of this section, if prior to receiving material from an entity or hospital on the prenatal testing services offered by such entity or hospital a patient requests a certain condition to be tested during the prenatal test, such condition shall be tested for if such test is available. When a patient receives the results of such prenatal test, if there is data on any condition tested such data shall be provided to the patient pursuant to subdivision b or c of this section.

e. Nothing contained in this section shall be construed to limit a health care practitioner licensed, certified, or authorized under title eight of the education law from recommending certain prenatal testing services according to the practitioner's reasonable and good faith professional judgment based on the facts of a patient's case.

§ 2. This act shall take effect on the thirtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to requiring a writ- ten notice on the occurrence of a false-positive result for any condi- tion tested during a prenatal test

Purpose

Requires a written notice on the occurrence of a false-positive result for any condition tested during a prenatal test.

Summary of provisions

Section 1: Amends the public health law by adding a new section 2533, which requires that every prenatal test must include a written notice of the occurrence of false-positive results for any condition tested, provided by the entity that created the test or advertises performing prenatal testing services. The written notice must be provided to the patient or potential parent prior to any prenatal test, with the test results, and with any advertisement, promotional brochure, website, or documentation provided by the entity. The written notice will be devel- oped by the Department of Health and include all data used by a labora- tory to determine false-positive results.

In addition, requires that hospitals or health care providers offering prenatal testing services provide a written notice of the occurrence of false positive results should the patient or potential parent not have received such materials from the entity which manufactured, supplied, or otherwise created such test or which advertised performing prenatal tests.

If data cannot be obtained for a condition tested by a prenatal test to be used in the written notice, then the condition cannot be offered to a patient or potential parent for prenatal testing services.

Section 2: Sets effective date.

Justification

Knowledge is essential to empower patients to make informed decisions about their treatment. The proliferation of prenatal genetic testing has provided healthcare providers and prospective parents with an ever-ex- panding list of conditions for which a fetus can be tested early in pregnancy.

Unfortunately, recent media reports have found that testing companies are not providing doctors and patients with relevant information on the high rate of false positive outcomes when testing for statistically rare developmental conditions. In some cases, these tests have false positive rates as high as 85-90%, yet on product brochures prior to testing, and even on the test result sheets, companies describe the test results as near certain in accuracy (language such as "reliable," "highly accu- rate," "total confidence," and "peace of mind" are included in promo- tional advertising and documentation provided by testing companies).

This bill would require testing companies to provide the data they already possess regarding false positive test rates to the commissioner of the department of health. The department would be tasked with using this data to draft written notice for healthcare providers to provide to prospective parents both prior to and at the receipt of testing results. Such language would be required by this bill to be understandable and easily visible when provided. In no way is this bill intending to contradict the advice of a healthcare provider to a patient, but rather to make sure commercial vendors are sharing information they already possess to better inform New York State healthcare professionals and especially prospective parents.

Legislative history

New bill.

Fiscal implications

Minimal costs to the Department of Health to be determined.

Effective date

This act shall take effect on the thirtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.